Biocon Consulting
Corporation
BUSINESS PLAN PRESENTATION
Excellence in Life Sciences
W ORLDW IDE COMMERCIALIZATION OF NEW AND INNOVATIVE TECHNOLOGIES IN
BIOTECHNOLOGY, MEDICAL DEV...
Positioning
• Product development within Life Sciences is traditionally done
  entirely in-house, however the growing tren...
Competition
• Biocon Consulting is not competing with traditional
  consulting companies, because we commercialize
  exist...
The Team
•   CEO Margita Engstrom
•   CEO Herve JACQUIAU (under discussion)
•   CTO Fred Thiel (under discussion)
•   CFO ...
Biocon Consulting Corporation




                                6
Market Summary
• The new product development (NPD) cycle pressure to
  decreased the time to market and costs The companie...
Threats and Opportunities
          • Increased regulations                                • Able to offer global
        ...
Business Concept
• Biocon Consulting commercializes new and innovative products
  and services into the global market plac...
Goals and Objectives
• Biocon Consulting Corporation is born global. The goal is to
  during the first year have running o...
Financial Plan
• The sales forecast is based on 6 offices/JV and 4
  product lines
   –   CROs and Contract Manufacturing ...
Financial plan
• The fundraising need for the beginning of the first
  year is 1 200 000$ in stocks and 300 000 by other
 ...
Resource Requirements
•   The successful implementation of the business plan requires for the following resources:
     – ...
Risks and Rewards
• .                                                                            • Huge growth potential w...
Key Issues
•   Short term
     –   Contracting with the suppliers of the newest services and products companies, offering ...
Upcoming SlideShare
Loading in …5
×

Business Plan 11 Sep 2008

955 views

Published on

Excellence in creating and building up compnies globally. Did you know thet in 2010 three times more IPOs are expected in te US?

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
955
On SlideShare
0
From Embeds
0
Number of Embeds
9
Actions
Shares
0
Downloads
19
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Business Plan 11 Sep 2008

  1. 1. Biocon Consulting Corporation BUSINESS PLAN PRESENTATION
  2. 2. Excellence in Life Sciences W ORLDW IDE COMMERCIALIZATION OF NEW AND INNOVATIVE TECHNOLOGIES IN BIOTECHNOLOGY, MEDICAL DEVICES AND PHARMACEUTICAL DRUG DEVELOPMENT. THE MISSION OF BIOCON CONSULTING CORPORATION IS TO BECOME THE LEADING NETW ORK FOR BRINGING THE MOST INNOVATIVE PRODUCTS INTO MEDICAL MARKETS
  3. 3. Positioning • Product development within Life Sciences is traditionally done entirely in-house, however the growing trend is to outsource services from expert organizations in order to decrease time to market and increase quality. • The NPD companies do apply new technologies in order to increase quality and efficiency of their processes. • The emergence of service organizations has increased efficiency of firms to allocate their financial and human resources according to their corporate strategy and core competences due to outsourcing of data intensive clinical trials for example. • Biocon Consulting is a unique network of suppliers due to its critical presence in the high tech clusters worldwide • Thus Biocon Consulting is proposing a portfolio of product and services for commercialization of innovations and new technologies for the R&D of MNEs and SMEs within the industry • Biocon Consulting works only in the high end niche. 3
  4. 4. Competition • Biocon Consulting is not competing with traditional consulting companies, because we commercialize existing innovative products and servcies • Biocon is offering a portfolio of service related to commercialization of new - innovative –high technologies within Life Sciences (niche) • Compared to traditional (usually local) distrubutors, Biocon Consulting offers know how and skills in the entire commercialization chain from innovations to ready products of latest technology • Biocon Consulting is operating worldwide, and its present in the most innovatove regions of the world in Life Sciences is critical for knowledge transfer. 4
  5. 5. The Team • CEO Margita Engstrom • CEO Herve JACQUIAU (under discussion) • CTO Fred Thiel (under discussion) • CFO to be recruited • Managing Director USA and Americas Chris Behrenbruch (under negotiation) • Managing Director India to be recruited • JV in Japan • Managing Director France Fabrice Plasson (under discussion) • Managing Director UK: Peter Benson under negotiation • Managing Director Finland Margita Engstrom 5
  6. 6. Biocon Consulting Corporation 6
  7. 7. Market Summary • The new product development (NPD) cycle pressure to decreased the time to market and costs The companies are facing more global competition, in addition to increase in effort to achieve global regulatory compliance, putting even more pressure on NPD. • By offering a global network of the best products and services in the world, Biocon Consulting is able to compete inquality and time to market with technology leadership. • Biocon Consulting is networked with financial, technology and research centers, service and product providers the global market place aiming at providing technology leadership. • We are in the business commercialization of unique and carefully selected products, services, innovations and technologies to the R&D processes of our clients. 7
  8. 8. Threats and Opportunities • Increased regulations • Able to offer global • Increased product recalls compliance due to global Quality • No uniform global regulations Global network • Knowledge of global organization compliance due to global presence • Able to produce high quality • Due to quality concerns services at low cost since and complex regulatory access to global production compliance the cost of Networked centers • Virtual hierarchy erases Cost NPD tend to increase organization troublesome hierarchy and inefficient administration • By being present in all the global • The time to market has « Silicon valleys« Biocon Consulting decreased for some market has access to technology leadership areas, however the • The strategy is to use new pressure to improve is Technology technologies in order to decrease Time to continuously present leadership cost, improve quality and decrease time to market. market • There is no room to be late- somewhat late in market launch can decrease the profits by 2/3. 8
  9. 9. Business Concept • Biocon Consulting commercializes new and innovative products and services into the global market place that improves quality, decreases cost and time to market of compared to traditional NPD methods (depend on the product/service). • Biocon Consulting enhances the development of new technologies by working with institutions, research centers, and business incubators by helping them commercializing innovation- by taking them rapidly through the NPD pipeline with fundraising services, search of qualified personnel and integrating them to our network (resulting in network effects and learning). • The strategy is to secure cash inflows from the beginning through commercialization of innovative products and services, plus ensuring long-term income by involving already at the basic research and innovation phase of new technologies-that becomes products on the market one day. 9
  10. 10. Goals and Objectives • Biocon Consulting Corporation is born global. The goal is to during the first year have running operations in all six market areas. • The net income for 2008 is estimated to be 400 k EUR. • The net income for 2009-2013 (after fundraising and expansion) is increasing from 950 k$ to 18M$ in 5 years. • The lean organization and being a service house commercializing products and innovations, enable a high profit margin • The goal is to double the sales revenue each year, an acquiring more personnel to ensure growth. • The 5th year exit strategy for the investors is a buyout: MBO or M&A with a return multiple of 10. 10
  11. 11. Financial Plan • The sales forecast is based on 6 offices/JV and 4 product lines – CROs and Contract Manufacturing Organizations – Financial services (fundraising and IP sales/licensing) – Medical technology – Biotechnology • Each office is estimated to do 2 deals in each product line the first year (modest estimation) • The sales forecast is estimated to grow significantly each year due to network effects and learning 11
  12. 12. Financial plan • The fundraising need for the beginning of the first year is 1 200 000$ in stocks and 300 000 by other method in order to – Set up the corporation in The USA and the subsidiaries – Recruitment – Acquisition of material (PC, office, licenses) – Cars, offices are leased, not purchased. • The first year is profitable and net income is increasing from year to year without substantial reinvestment (with the exception of some more employees) 12
  13. 13. Resource Requirements • The successful implementation of the business plan requires for the following resources: – Personnel: • Access to highly educated personnel with knowledge of the latest technologies • Access to senior level personnel with excellent network and capable to leading a team of multicultural and ambitious members • Motivation is enhanced by option program to the managers – Technology • Biocon Consulting will continue to identify high potential technologies and to network (collaborate to compete) – Finances • Access to Business Angel investments and venture capitalists with experience of this business model and the latest technologies – Distribution • Distribution is outsourced to global distributors if possible, local when necessary. – Promotion • Strong virtual presence. Excellent internet site in multilanguage with client and partner login. Access to confidential information strictly controlled – Products and Innovation to be commercialized • New and innovative products. More information upon signature of NDA – Services to be commercialized • Contracts with: CRO services, financial services, business development services, consulting services, industrial design services, partnering services, networking services, M&A advisory, IP services, marketing services and research, technology and financial evaluation, private equity services entrepreneurial education services, legal services, manufacturing organizations: working on a commission base on global sales 13
  14. 14. Risks and Rewards • . • Huge growth potential with high margins • Access to sufficient capital to start • Risk is managed by selecting only the best globally Financial into the network. Fewer, but with high quality, Financial risk • Access to financial partners and mentors reward high integrity and exclusive agreements. • Royalty income from early involvement at the willing to work globally NPD phase (innovation) • Only strong IP technologies incorporated into • Being able to sign collaborative the Biocon Consulting network Technological agreements with the high technology Technological • High NDA policy partners prospected risk • Is the new technology successful? reward • Partnering with competitors if collaboration enhances market acceptance and increase • IP regulations not uniform globally knowledge • Shifts in economical trends might affect • Biocon Consulting emphasizes on value the market potential added services and products with low cost Market thanks to technologies that enable this Market risk • The market may not absorb the best reward • Client needs taken into account early in the technology but the most ergonomic or NPD process (design, marketing, look, feel) convenient or most good looking product. 14
  15. 15. Key Issues • Short term – Contracting with the suppliers of the newest services and products companies, offering solutions that the industry is ready to adapt immediately – Partnering globally with top tier product and services providers in order to be able to shorten the NPD time at a high quality, low cost and excellent user adaptability. – The consequences of postponing this decision has an impact on short-term cash flow. • Long term – Partnering with incubators and research centers in order to involve them early in the commercialization process. The issue is to be able to evaluate innovations that have a commercial success. – Partnering with universities to follow up basic research trends, and identifying those willing to becoming entrepreneurs or willing to commercialize or sell their innovation.. – The consequences of postponing this decision has an impact on long-term cash flow. – . • The financial critical issues are being able to operate in the 6 areas, hire the Directors and find technology consultants and sales personnel shortly (by the end of 2008). Due to the global network organization the need for facilities is limited and does not need huge financial investments, however high performance computing technologies are needed. 15

×